Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.

Unemo M, Golparian D, Sánchez-Busó L, Grad Y, Jacobsson S, Ohnishi M, Lahra MM, Limnios A, Sikora AE, Wi T, Harris SR.

J Antimicrob Chemother. 2016 Nov;71(11):3096-3108. Epub 2016 Jul 17.

PMID:
27432602
2.

Australian Gonococcal Surveillance Programme annual report, 2014.

Lahra MM; Australian Gonococcal Surveillance Programme..

Commun Dis Intell Q Rep. 2015 Sep 30;39(3):E347-54.

3.

Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Australia.

Stevens K, Zaia A, Tawil S, Bates J, Hicks V, Whiley D, Limnios A, Lahra MM, Howden BP.

J Antimicrob Chemother. 2015 Apr;70(4):1267-8. doi: 10.1093/jac/dku490. Epub 2014 Dec 4. No abstract available.

PMID:
25480491
4.

Penicillinase-producing plasmid types in Neisseria gonorrhoeae clinical isolates from Australia.

Whiley D, Trembizki E, Buckley C, Freeman K, Lawrence A, Limnios A, Pearson J, Smith H, Stevens K, Lahra MM.

Antimicrob Agents Chemother. 2014 Dec;58(12):7576-8. doi: 10.1128/AAC.04120-14. Epub 2014 Sep 29.

5.

A national quality assurance survey of Neisseria gonorrhoeae testing.

Trembizki E, Lahra M, Stevens K, Freeman K, Hogan T, Hogg G, Lawrence A, Limnios A, Pearson J, Smith H, Nissen M, Sloots T, Whiley D; GRAND study investigators..

J Med Microbiol. 2014 Jan;63(Pt 1):45-9. doi: 10.1099/jmm.0.065094-0. Epub 2013 Oct 3.

PMID:
24092762
6.

Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.

Tabrizi SN, Unemo M, Golparian D, Twin J, Limnios AE, Lahra M, Guy R; TTANGO Investigators..

J Clin Microbiol. 2013 Jun;51(6):1945-7. doi: 10.1128/JCM.00806-13. Epub 2013 Apr 3.

7.

Australian Gonococcal Surveillance Programme annual report, 2012.

Lahra MM; Australian Gonococcal Surveillance Programme..

Commun Dis Intell Q Rep. 2013 Sep 30;37(3):E233-9.

8.

Annual report of the Australian Gonococcal Surveillance Programme, 2011.

Lahra MM; Australian Gonococcal Surveillance Programme..

Commun Dis Intell Q Rep. 2012 Jun 30;36(2):E166-73.

9.

The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance.

Goire N, Freeman K, Lambert SB, Nimmo GR, Limnios AE, Lahra MM, Nissen MD, Sloots TP, Whiley DM.

Sex Health. 2012 Nov;9(5):422-9. doi: 10.1071/SH12026.

PMID:
23036167
10.

Real-time PCR genotyping of Neisseria gonorrhoeae isolates using 14 informative single nucleotide polymorphisms on gonococcal housekeeping genes.

Whiley DM, Goire N, Rahimi F, Lahra MM, Limnios AE, Nissen MD, Sloots TP.

J Antimicrob Chemother. 2013 Feb;68(2):322-8. doi: 10.1093/jac/dks381. Epub 2012 Sep 21.

PMID:
23002175
11.

Australian Gonococcal Surveillance Programme annual report, 2010.

Australian Gonococcal Surveillance Programme..

Commun Dis Intell Q Rep. 2011 Sep;35(3):229-36.

12.

Australian Meningococcal Surveillance Programme annual report, 2010.

Australian Meningococcal Surveillance Programme..

Commun Dis Intell Q Rep. 2011 Sep;35(3):217-28.

13.

The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.

Whiley DM, Goire N, Lahra MM, Donovan B, Limnios AE, Nissen MD, Sloots TP.

J Antimicrob Chemother. 2012 Sep;67(9):2059-61. doi: 10.1093/jac/dks188. Epub 2012 May 17. Review.

PMID:
22604449
14.

In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?

Unemo M, Golparian D, Limnios A, Whiley D, Ohnishi M, Lahra MM, Tapsall JW.

Antimicrob Agents Chemother. 2012 Jul;56(7):3603-9. doi: 10.1128/AAC.00326-12. Epub 2012 Apr 30.

15.

Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain.

Goire N, Ohnishi M, Limnios AE, Lahra MM, Lambert SB, Nimmo GR, Nissen MD, Sloots TP, Whiley DM.

J Antimicrob Chemother. 2012 Apr;67(4):902-5. doi: 10.1093/jac/dkr549. Epub 2011 Dec 29.

PMID:
22207596
16.

Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species.

Tabrizi SN, Unemo M, Limnios AE, Hogan TR, Hjelmevoll SO, Garland SM, Tapsall J.

J Clin Microbiol. 2011 Oct;49(10):3610-5. doi: 10.1128/JCM.01217-11. Epub 2011 Aug 3.

17.

False-negative results using Neisseria gonorrhoeae porA pseudogene PCR - a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011.

Whiley DM, Limnios A, Moon NJ, Gehrig N, Goire N, Hogan T, Lam A, Jacob K, Lambert SB, Nissen MD, Sloots TP.

Euro Surveill. 2011 May 26;16(21). pii: 19874.

18.

Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.

Limnios A, Tapsall J, Kahlmeter J, Hogan T, Ray S, Lam A, Unemo M.

APMIS. 2011 Jun;119(6):356-63. doi: 10.1111/j.1600-0463.2011.02729.x. Epub 2011 Feb 24.

PMID:
21569093
19.

Annual report of the Australian Meningococcal Surveillance Programme, 2009.

Australian Meningococcal Surveillance Programme..

Commun Dis Intell Q Rep. 2010 Sep;34(3):291-302.

20.

Evaluation of the cobas 4800 CT/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae.

Rockett R, Goire N, Limnios A, Turra M, Higgens G, Lambert SB, Bletchly C, Nissen MD, Sloots TP, Whiley DM.

Sex Transm Infect. 2010 Nov;86(6):470-3. doi: 10.1136/sti.2010.042812. Epub 2010 Aug 18.

PMID:
20719957

Supplemental Content

Loading ...
Support Center